“…In addition to cPLA 2 , accumulating evidence also shows that other forms of PLA 2 s, including type II secretory PLA 2 (sPLA 2 ), may also participate in the release of AA release in various types of cells. Numerous studies have documented the involvement of AA metabolites, PGs, and leukotrienes in various liver physiological and pathophysiological processes including liver regeneration, growth regulation of hepatocytes, inflammation, cirrhosis, and hepatocytic ischemic/hypoxic injuries (31,36,37,49,51,53,59). However, the detailed mechanisms for their actions and the regulation of the key eicosanoid-forming enzymes in liver tissue or liver cells are not well understood.…”